The Aptamer Group of companies focuses on the development of nucleic acid aptamers for a number of diverse and innovative uses, ranging from research and development and diagnostics, to therapeutic applications. Aptamers are short DNA or RNA sequences that offer high-affinity and specificity to a vast range of targets such as proteins, cells, peptides, micro-organisms and small molecules. They are versatile and cost effective and offer a complementary or alternative solution to antibodies.